Published in Sleep on December 01, 2013
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med (2002) 14.26
Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med (2001) 3.95
Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation (2005) 2.99
Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med (2007) 2.62
Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation (2007) 2.29
Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes (1999) 2.03
Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res (1999) 1.99
Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care (2007) 1.88
Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest (2008) 1.84
Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol (2012) 1.80
Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med (2004) 1.74
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis (2002) 1.59
Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease. Circ Res (2009) 1.58
Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients. Atherosclerosis (2007) 1.35
Fatty acid binding protein expression in different adipose tissue depots from lean and obese individuals. Diabetologia (2001) 1.33
[Validation of the Spanish version of the Epworth Sleepiness Scale in patients with a sleep apnea syndrome]. Arch Bronconeumol (1999) 1.30
Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J (2006) 1.19
Influence of constant positive airway pressure therapy on lipid storage, muscle metabolism and insulin action in obese patients with severe obstructive sleep apnoea syndrome. Diabetes Obes Metab (2007) 1.17
Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis (2010) 1.16
Sonographic assessment of regional adiposity. AJR Am J Roentgenol (2007) 1.12
Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol (2012) 1.08
Lipid chaperones and metabolic inflammation. Int J Inflam (2011) 1.03
Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia. Am J Respir Cell Mol Biol (2010) 0.98
A microarray analysis of the hypoxia-induced modulation of gene expression in human adipocytes. Arch Physiol Biochem (2012) 0.96
Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis. Eur Heart J (2008) 0.96
FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis (2012) 0.88
Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med (2011) 0.86
Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance. Eur Respir J (2009) 0.86
Different association of circulating levels of adipocyte and epidermal fatty acid-binding proteins with metabolic syndrome and coronary atherosclerosis in Chinese adults. Atherosclerosis (2011) 0.84
Serum levels of adipocyte fatty acid-binding protein are independently associated with left ventricular mass and myocardial performance index in obstructive sleep apnea syndrome. J Investig Med (2012) 0.80
Treatment of obstructive sleep apnea with continuous positive airway pressure decreases adipocyte fatty acid-binding protein levels. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2012) 0.77
APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. Atherosclerosis (2009) 1.56
FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway. PLoS One (2013) 1.52
[Factors influencing incipient diabetic nephropathy: ESODIAH study]. Med Clin (Barc) (2005) 1.38
Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease. Curr Opin Clin Nutr Metab Care (2003) 1.26
Protease inhibitor-associated dyslipidemia in HIV-infected patients is strongly influenced by the APOA5-1131T->C gene variation. Clin Chem (2006) 1.16
Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine. AIDS (2002) 1.15
Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem (2002) 1.11
Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes. J Lipid Res (2008) 1.11
Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells. Cardiovasc Diabetol (2012) 1.08
Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients. AIDS (2004) 1.04
Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria. Clin Chem (2007) 1.02
Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers. J Rheumatol (2002) 0.97
Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes. Atherosclerosis (2010) 0.93
Prox-1 and FOXC2 gene expression in adipose tissue: A potential contributory role of the lymphatic system to familial combined hyperlipidaemia. Atherosclerosis (2009) 0.92
FABP4 predicts atherogenic dyslipidemia development. The PREDIMED study. Atherosclerosis (2012) 0.88
Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients. Nutr Metab Cardiovasc Dis (2007) 0.88
Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension. PLoS One (2012) 0.88
Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome. Clin Nutr (2010) 0.88
Prevalence of and predictors of bicuspid aortic valves in patients with dilated aortic roots. Am J Cardiol (2003) 0.87
Polyunsaturated fatty acids down-regulate in vitro expression of the key intestinal cholesterol absorption protein NPC1L1: no effect of monounsaturated nor saturated fatty acids. J Nutr Biochem (2009) 0.87
FABP4 plasma levels are increased in familial combined hyperlipidemia. J Lipid Res (2010) 0.87
Gene expression analysis of a human enterocyte cell line reveals downregulation of cholesterol biosynthesis in response to short-chain fatty acids. IUBMB Life (2008) 0.86
Tumor necrosis factor-alpha -1031 T/C polymorphism is associated with smaller and more proatherogenic low density lipoprotein particles in patients with rheumatoid arthritis. J Rheumatol (2008) 0.85
Small artery dilation and endothelial markers in cardiovascular risk patients. Eur J Clin Invest (2011) 0.85
Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages. Atherosclerosis (2002) 0.84
Increased concentrations of circulating vitamin E in carriers of the apolipoprotein A5 gene - 1131T>C variant and associations with plasma lipids and lipid peroxidation. J Lipid Res (2007) 0.83
The apolipoprotein A5 gene -1131T-->C polymorphism affects vitamin E plasma concentrations in type 2 diabetic patients. Clin Chem Lab Med (2008) 0.83
Additive effects of the PPARgamma, APOE, and FABP-2 genes in increasing daylong triglycerides of normolipidemic women to concentrations comparable to those in men. Clin Chem (2005) 0.82
Substituting non-HDL cholesterol with LDL as a guide for lipid-lowering therapy increases the number of patients with indication for therapy. Atherosclerosis (2012) 0.82
Effects of soluble fiber (Plantago ovata husk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease. Am J Clin Nutr (2007) 0.81
Retinoic acid induces PGI synthase expression in human endothelial cells. J Lipid Res (2008) 0.81
Cocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trial. PLoS One (2012) 0.81
HDL derived from the different phases of conjugated diene formation reduces membrane fluidity and contributes to a decrease in free cholesterol efflux from human THP-1 macrophages. Biochim Biophys Acta (2003) 0.80
Association of a polymorphism in the promoter of the cellular retinoic acid-binding protein II gene (CRABP2) with increased circulating low-density lipoprotein cholesterol. Clin Chem Lab Med (2007) 0.80
Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy. Anal Bioanal Chem (2012) 0.79
Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients. Cardiovasc Diabetol (2013) 0.79
Phytosterols inhibit the tumor growth and lipoprotein oxidizability induced by a high-fat diet in mice with inherited breast cancer. J Nutr Biochem (2012) 0.78
Nuclear magnetic resonance lipoprotein subclasses and the APOE genotype influence carotid atherosclerosis in patients with systemic lupus erythematosus. J Rheumatol (2010) 0.78
Akt and ERK/Nrf2 activation by PUFA oxidation-derived aldehydes upregulates FABP4 expression in human macrophages. Atherosclerosis (2013) 0.77
Negative effect of a low-carbohydrate, high-protein, high-fat diet on small peripheral artery reactivity in patients with increased cardiovascular risk. Br J Nutr (2012) 0.77
Two novel single nucleotide polymorphisms in the promoter of the cellular retinoic acid binding protein II gene (CRABP-II). Mol Cell Probes (2003) 0.77
Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess. Gynecol Endocrinol (2011) 0.77
[Micronutrients in HIV-infection and the relationship with the inflammatory response]. Med Clin (Barc) (2002) 0.77
Cytotoxic effects of the lipid peroxidation product 2,4-decadienal in vascular smooth muscle cells. Atherosclerosis (2003) 0.76
Even low physical activity levels improve vascular function in overweight and obese postmenopausal women. Menopause (2013) 0.76
Aldehydes mediate tissue factor induction: a possible mechanism linking lipid peroxidation to thrombotic events. J Cell Physiol (2004) 0.76
Correction: FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway. PLoS One (2016) 0.75
Effect of 13-cis-retinoic acid on the genetic expression profile of human umbilical vein endothelial cells (HUVECs) determined by microarray. Clin Chem Lab Med (2007) 0.75
[Tables for cholesterol lowering therapy planning. An update]. Med Clin (Barc) (2010) 0.75
[Which cardiovascular risk tables should we use?]. Rev Esp Cardiol (2007) 0.75
Generation of eight adjacent mutations in a single step using a site-directed mutagenesis kit. Clin Chem Lab Med (2004) 0.75
[Expert consensus on the detection and clinical management of familial hypercholesterolemia]. Clin Investig Arterioscler (2013) 0.75
First human isolate of Mycobacterium madagascariense in the sputum of a patient with tracheobronchitis. Clin Chem Lab Med (2013) 0.75
Lifestyle changes lower FABP4 plasma concentration in patients with cardiovascular risk. Rev Esp Cardiol (Engl Ed) (2011) 0.75
[Respiratory failure secondary to multiple pulmonary arteriovenous malformations]. Med Clin (Barc) (2006) 0.75